Bebashi - Transition to Hope

Audits
3
Findings
21
Total Expended
$5.66M
Latest Accepted
2025-09-30
Location: Philadelphia, PA
UEI: YJTMZ9HPPEH3 EIN: 232484046

SAM.gov Exclusion Status:

Checking exclusion status...

Contacts

Name Title Type
Nafisah Houston Chief Operating Officer Auditee
Sebrina Tate Executive Director Auditee
Wilfredo Torres Director of Finance Auditee
Eric Strauss Partner Auditee
No contacts on file

Recent Audits

ID Year Date Accepted Auditor Spend
368952 2024 2025-09-30 Withum Smith+brown PC $2.09M
308741 2023 2024-06-13 Withum Smith+brown PC $1.77M
15104 2022 2024-02-01 Withum Smith+brown PC $1.80M

Audit Findings

Audit Year Accepted Finding Ref Severity Repeat Requirement
368952 2024 2025-09-30 1156603 2024-001 Material Weakness Yes L
368952 2024 2025-09-30 1156602 2024-001 Material Weakness Yes L
368952 2024 2025-09-30 1156601 2024-001 Material Weakness Yes L
368952 2024 2025-09-30 1156600 2024-001 Material Weakness Yes L
368952 2024 2025-09-30 1156599 2024-001 Material Weakness Yes L
308741 2023 2024-06-13 977126 2023-001 Significant Deficiency Yes L
308741 2023 2024-06-13 977125 2023-001 Significant Deficiency Yes L
308741 2023 2024-06-13 977124 2023-001 Significant Deficiency Yes L
308741 2023 2024-06-13 977123 2023-001 Significant Deficiency Yes L
308741 2023 2024-06-13 400684 2023-001 Significant Deficiency Yes L
308741 2023 2024-06-13 400683 2023-001 Significant Deficiency Yes L
308741 2023 2024-06-13 400682 2023-001 Significant Deficiency Yes L
308741 2023 2024-06-13 400681 2023-001 Significant Deficiency Yes L
15104 2022 2024-02-01 587731 2022-001 Significant Deficiency Yes L
15104 2022 2024-02-01 587730 2022-001 Significant Deficiency Yes L
15104 2022 2024-02-01 587729 2022-001 Significant Deficiency Yes L
15104 2022 2024-02-01 587728 2022-001 Significant Deficiency Yes L
15104 2022 2024-02-01 11289 2022-001 Significant Deficiency Yes L
15104 2022 2024-02-01 11288 2022-001 Significant Deficiency Yes L
15104 2022 2024-02-01 11287 2022-001 Significant Deficiency Yes L
15104 2022 2024-02-01 11286 2022-001 Significant Deficiency Yes L